迈普医学：公司的3D打印技术主要用于体外组织模型或活体组织构建等前沿科学及临床应用研究

Core Viewpoint - The company is a leading innovative enterprise in China that utilizes bio-additive manufacturing technology to develop absorbable dura (spinal) membrane patches [1] Group 1: Company Overview - The company employs 3D printing technology primarily for in vitro tissue models and in vivo tissue construction, focusing on cutting-edge scientific and clinical application research [1] - Xu Tao, the actual controller of the company, is also a significant shareholder and currently serves as the director of the Shenzhen Tsinghua University Research Institute [1]